Invokana
Payments companies reported to CMS as associated with Invokana. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Invokana, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Invokana
These are the largest totals companies reported as associated with Invokana. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Januzzi | Boston, MA | Cardiovascular Disease | $17,750.00 |
| Lori Laffel | Boston, MA | Pediatric Endocrinology | $4,400.00 |
| Ulhas Nadgir | Sacramento, CA | Pediatric Endocrinology | $1,875.00 |
| Christian Stanley | Philadelphia, PA | Nurse Practitioner | $1,600.00 |
| Denis Ruiz Serrano | Guaynabo, PR | Cardiovascular Disease | $155.91 |
| Hector Mendez Rivera | Carolina, PR | Cardiovascular Disease | $101.68 |
| William Borges Cancel | San Juan, PR | Cardiovascular Disease | $97.08 |
| Caitlyn Turpin | Memphis, TN | Family | $89.09 |
| Rafael Rivera | Ponce, PR | Interventional Cardiology | $87.73 |
| Jorge Leavitt Caraballo | Aibonito, PR | Cardiovascular Disease | $85.22 |
Prescribed Invokana?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.